features: MRD

A session with UK experts Graham Collins and Wendy Osborne, who discuss the key lymphoma highlights presented at ASH 2020.

A session with UK experts Rakesh Popat and Karthik Ramasamy, who discuss the latest myeloma news from ASH 2020.

A session with experts Morie Gertz, Vaishali Sanchorawala, Raymond Comenzo & Ashutosh Wechalekar, who discuss the latest amyloidosis updates from…

A session with experts Stephen Ansell and Graham Collins, who discuss the latest lymphoma updates from ASH 2020.

A session with experts Naval Daver, David Sallman, Eunice Wang & Amir Fathi, who discuss the latest updates in acute…

A session with experts María-Victoria Mateos, Nina Shah & Thomas Martin, who discuss the latest myeloma updates from ASH 2020.

A session with experts John Gribben, Alessandra Tedeschi, Meghan Thompson & Matthew Davids, who discuss the latest chronic lymphocytic leukemia…

VJHemOnc is proud to present the NYC-Miami Myeloma MRD 2020 Virtual Meeting, which took place on the 8th of October…

The U.S. Food and Drug Administration (FDA) has approved the first and only assay – clonoSEQ®, to screen and assess…

A five-part session with experts John Gribben, Barbara Eichhorst, Susan O’Brien and Matthew Davids who debate the key updates in…

In this session, Amer Zeidan, John Mascarenhas, Jan Bewersdorf & Rory Shallis discuss and debate the special considerations for managing…

A three-part session with experts Naval Daver, Marion Subklewe, Andrew Wei & Amir Fathi discussing updates from the ASCO &…

Exclusive podcast with Prof. Graham Jackson who explains the current treatment landscape in multiple myeloma.

Recently published in the Journal of Clinical Oncology, work from the Hourigan Lab (National Heart, Lung, and Blood Institute, National…

COMy 2019: Measurable Residual Disease (MRD) as a tool in the management of myeloma patients.

VJHemOnc is pleased to bring you e-learning webcasts from iwAL 2019. Catch up on key topics in acute leukemias now!